Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2023

Upgrades

Piper Sandler upgraded the previous rating for Aligos Therapeutics Inc ALGS from Neutral to Overweight. Aligos Therapeutics earned $0.44 in the third quarter, compared to $0.78 in the year-ago quarter. The current stock performance of Aligos Therapeutics shows a 52-week-high of $11.82 and a 52-week-low of $0.84. Moreover, at the end of the last trading period, the closing price was at $0.99.

According to Raymond James, the prior rating for TC Energy Corp TRP was changed from Market Perform to Outperform. For the third quarter, TC Energy had an EPS of $0.82, compared to year-ago quarter EPS of $0.79. The stock has a 52-week-high of $59.38 and a 52-week-low of $38.35. At the end of the last trading period, TC Energy closed at $38.53.

For Skechers USA Inc SKX, Argus Research upgraded the previous rating of Hold to Buy. Skechers USA earned $0.55 in the third quarter, compared to $0.66 in the year-ago quarter. At the moment, the stock has a 52-week-high of $49.89 and a 52-week-low of $31.28. Skechers USA closed at $43.22 at the end of the last trading period.

For LifeStance Health Group Inc LFST, Morgan Stanley upgraded the previous rating of Equal-Weight to Overweight. In the third quarter, LifeStance Health Gr showed an EPS of $0.11, compared to $0.35 from the year-ago quarter. The stock has a 52-week-high of $11.25 and a 52-week-low of $4.22. At the end of the last trading period, LifeStance Health Gr closed at $4.40.

For Sight Sciences Inc SGHT, Stifel upgraded the previous rating of Hold to Buy. For the third quarter, Sight Sciences had an EPS of $0.46, compared to year-ago quarter EPS of $0.43. The current stock performance of Sight Sciences shows a 52-week-high of $18.25 and a 52-week-low of $5.35. Moreover, at the end of the last trading period, the closing price was at $11.82.

For Borr Drilling Ltd BORR, BTIG upgraded the previous rating of Neutral to Buy. Borr Drilling earned $0.30 in the third quarter, compared to $0.24 in the year-ago quarter. At the moment, the stock has a 52-week-high of $6.96 and a 52-week-low of $1.75. Borr Drilling closed at $4.79 at the end of the last trading period.

For Western Digital Corp WDC, Benchmark upgraded the previous rating of Sell to Hold. Western Digital earned $0.20 in the first quarter, compared to $2.49 in the year-ago quarter. At the moment, the stock has a 52-week-high of $69.36 and a 52-week-low of $29.73. Western Digital closed at $35.23 at the end of the last trading period.

According to Wells Fargo, the prior rating for Sunnova Energy International Inc NOVA was changed from Equal-Weight to Overweight. For the third quarter, Sunnova Energy Intl had an EPS of $0.54, compared to year-ago quarter EPS of $0.25. At the moment, the stock has a 52-week-high of $31.47 and a 52-week-low of $12.47. Sunnova Energy Intl closed at $17.10 at the end of the last trading period.

Wells Fargo upgraded the previous rating for First Solar Inc FSLR from Equal-Weight to Overweight. For the third quarter, First Solar had an EPS of $0.46, compared to year-ago quarter EPS of $0.42. At the moment, the stock has a 52-week-high of $173.68 and a 52-week-low of $59.60. First Solar closed at $145.46 at the end of the last trading period.

For SunPower Corp SPWR, Wells Fargo upgraded the previous rating of Underweight to Equal-Weight. SunPower earned $0.13 in the third quarter, compared to $0.06 in the year-ago quarter. At the moment, the stock has a 52-week-high of $28.42 and a 52-week-low of $12.78. SunPower closed at $16.74 at the end of the last trading period.

According to Wells Fargo, the prior rating for Stitch Fix Inc SFIX was changed from Underweight to Equal-Weight. In the first quarter, Stitch Fix showed an EPS of $0.50, compared to $0.02 from the year-ago quarter. At the moment, the stock has a 52-week-high of $20.17 and a 52-week-low of $2.63. Stitch Fix closed at $3.50 at the end of the last trading period.

According to JP Morgan, the prior rating for Voya Financial Inc VOYA was changed from Neutral to Overweight. Voya Financial earned $2.30 in the third quarter, compared to $1.36 in the year-ago quarter. The current stock performance of Voya Financial shows a 52-week-high of $74.97 and a 52-week-low of $56.20. Moreover, at the end of the last trading period, the closing price was at $62.99.

Wells Fargo upgraded the previous rating for Lululemon Athletica Inc LULU from Equal-Weight to Overweight. In the third quarter, Lululemon Athletica showed an EPS of $2.00, compared to $1.62 from the year-ago quarter. At the moment, the stock has a 52-week-high of $410.70 and a 52-week-low of $251.51. Lululemon Athletica closed at $325.93 at the end of the last trading period.

Wells Fargo upgraded the previous rating for PVH Corp PVH from Equal-Weight to Overweight. In the third quarter, PVH showed an EPS of $2.60, compared to $2.67 from the year-ago quarter. The stock has a 52-week-high of $113.78 and a 52-week-low of $43.49. At the end of the last trading period, PVH closed at $76.84.

According to Cowen & Co., the prior rating for Molson Coors Beverage Co TAP was changed from Market Perform to Outperform. For the third quarter, Molson Coors Beverage had an EPS of $1.32, compared to year-ago quarter EPS of $1.75. The current stock performance of Molson Coors Beverage shows a 52-week-high of $60.12 and a 52-week-low of $46.69. Moreover, at the end of the last trading period, the closing price was at $49.58.

According to Wells Fargo, the prior rating for Sunrun Inc RUN was changed from Equal-Weight to Overweight. For the third quarter, Sunrun had an EPS of $0.96, compared to year-ago quarter EPS of $0.11. The stock has a 52-week-high of $39.13 and a 52-week-low of $16.80. At the end of the last trading period, Sunrun closed at $22.23.

For Aligos Therapeutics Inc ALGS, Jefferies upgraded the previous rating of Hold to Buy. For the third quarter, Aligos Therapeutics had an EPS of $0.44, compared to year-ago quarter EPS of $0.78. The stock has a 52-week-high of $11.82 and a 52-week-low of $0.84. At the end of the last trading period, Aligos Therapeutics closed at $0.99.

Jefferies upgraded the previous rating for Amarin Corp PLC AMRN from Hold to Buy. For the third quarter, Amarin Corp had an EPS of $0.02, compared to year-ago quarter EPS of $0.03. The current stock performance of Amarin Corp shows a 52-week-high of $3.81 and a 52-week-low of $1.04. Moreover, at the end of the last trading period, the closing price was at $1.26.

According to Deutsche Bank, the prior rating for PNC Financial Services Group Inc PNC was changed from Hold to Buy. For the third quarter, PNC Financial Services Gr had an EPS of $3.78, compared to year-ago quarter EPS of $3.75. The stock has a 52-week-high of $228.14 and a 52-week-low of $143.52. At the end of the last trading period, PNC Financial Services Gr closed at $159.37.

For Jacobs Solutions Inc J, Baird upgraded the previous rating of Neutral to Outperform. In the fourth quarter, Jacobs Solutions showed an EPS of $1.80, compared to $1.58 from the year-ago quarter. The current stock performance of Jacobs Solutions shows a 52-week-high of $150.32 and a 52-week-low of $106.78. Moreover, at the end of the last trading period, the closing price was at $123.61.

According to Baird, the prior rating for Allogene Therapeutics Inc ALLO was changed from Neutral to Outperform. In the third quarter, Allogene Therapeutics showed an EPS of $0.58, compared to $0.57 from the year-ago quarter. At the moment, the stock has a 52-week-high of $17.49 and a 52-week-low of $5.41. Allogene Therapeutics closed at $5.81 at the end of the last trading period.

Piper Sandler upgraded the previous rating for Zynex Inc ZYXI from Neutral to Overweight. In the third quarter, Zynex showed an EPS of $0.13, compared to $0.15 from the year-ago quarter. The current stock performance of Zynex shows a 52-week-high of $14.55 and a 52-week-low of $4.97. Moreover, at the end of the last trading period, the closing price was at $14.14.

For Regency Centers Corp REG, Baird upgraded the previous rating of Neutral to Outperform. Regency Centers earned $1.01 in the third quarter, compared to $1.12 in the year-ago quarter. The current stock performance of Regency Centers shows a 52-week-high of $78.45 and a 52-week-low of $51.97. Moreover, at the end of the last trading period, the closing price was at $62.29.

According to Baird, the prior rating for EastGroup Properties Inc EGP was changed from Neutral to Outperform. For the third quarter, EastGroup Props had an EPS of $1.77, compared to year-ago quarter EPS of $1.55. The stock has a 52-week-high of $223.21 and a 52-week-low of $137.47. At the end of the last trading period, EastGroup Props closed at $145.87.

JonesTrading upgraded the previous rating for Deciphera Pharmaceuticals Inc DCPH from Sell to Hold. Deciphera Pharmaceuticals earned $0.55 in the third quarter, compared to $1.37 in the year-ago quarter. At the moment, the stock has a 52-week-high of $21.21 and a 52-week-low of $6.51. Deciphera Pharmaceuticals closed at $20.25 at the end of the last trading period.

According to Baird, the prior rating for Hudson Pacific Properties Inc HPP was changed from Neutral to Outperform. For the third quarter, Hudson Pacific Properties had an EPS of $0.52, compared to year-ago quarter EPS of $0.50. At the moment, the stock has a 52-week-high of $28.66 and a 52-week-low of $9.16. Hudson Pacific Properties closed at $9.18 at the end of the last trading period.

See all analyst ratings upgrades.

Downgrades

For Embecta Corp EMBC, Morgan Stanley downgraded the previous rating of Equal-Weight to Underweight. In the fourth quarter, Embecta showed an EPS of $0.73, compared to $1.70 from the year-ago quarter. The stock has a 52-week-high of $36.64 and a 52-week-low of $23.62. At the end of the last trading period, Embecta closed at $25.14.

According to Craig-Hallum, the prior rating for Silvergate Capital Corp SI was changed from Buy to Hold. Silvergate Capital earned $1.28 in the third quarter, compared to $0.88 in the year-ago quarter. At the moment, the stock has a 52-week-high of $162.65 and a 52-week-low of $11.14. Silvergate Capital closed at $12.57 at the end of the last trading period.

For Agiliti Inc AGTI, Morgan Stanley downgraded the previous rating of Overweight to Equal-Weight. Agiliti earned $0.19 in the third quarter, compared to $0.23 in the year-ago quarter. The stock has a 52-week-high of $23.25 and a 52-week-low of $14.15. At the end of the last trading period, Agiliti closed at $16.24.

According to Morgan Stanley, the prior rating for Heska Corp HSKA was changed from Equal-Weight to Underweight. For the third quarter, Heska had an EPS of $0.41, compared to year-ago quarter EPS of $0.20. At the moment, the stock has a 52-week-high of $164.57 and a 52-week-low of $58.00. Heska closed at $62.54 at the end of the last trading period.

According to B of A Securities, the prior rating for Silvergate Capital Corp SI was changed from Neutral to Underperform. For the third quarter, Silvergate Capital had an EPS of $1.28, compared to year-ago quarter EPS of $0.88. The stock has a 52-week-high of $162.65 and a 52-week-low of $11.14. At the end of the last trading period, Silvergate Capital closed at $12.57.

According to B of A Securities, the prior rating for Fate Therapeutics Inc FATE was changed from Buy to Underperform. In the third quarter, Fate Therapeutics showed an EPS of $0.86, compared to $0.45 from the year-ago quarter. The current stock performance of Fate Therapeutics shows a 52-week-high of $56.64 and a 52-week-low of $9.56. Moreover, at the end of the last trading period, the closing price was at $11.00.

UBS downgraded the previous rating for Cano Health Inc CANO from Buy to Neutral. For the third quarter, Cano Health had an EPS of $0.23, compared to year-ago quarter EPS of $0.14. The current stock performance of Cano Health shows a 52-week-high of $9.75 and a 52-week-low of $0.98. Moreover, at the end of the last trading period, the closing price was at $1.10.

For Fate Therapeutics Inc FATE, Stifel downgraded the previous rating of Buy to Hold. Fate Therapeutics earned $0.86 in the third quarter, compared to $0.45 in the year-ago quarter. The current stock performance of Fate Therapeutics shows a 52-week-high of $56.64 and a 52-week-low of $9.56. Moreover, at the end of the last trading period, the closing price was at $11.00.

For Ballard Power Systems Inc BLDP, Wells Fargo downgraded the previous rating of Equal-Weight to Underweight. In the third quarter, Ballard Power Systems showed an EPS of $0.14, compared to $0.10 from the year-ago quarter. At the moment, the stock has a 52-week-high of $12.71 and a 52-week-low of $4.43. Ballard Power Systems closed at $5.04 at the end of the last trading period.

For Ulta Beauty Inc ULTA, Wells Fargo downgraded the previous rating of Equal-Weight to Underweight. Ulta Beauty earned $5.34 in the third quarter, compared to $3.94 in the year-ago quarter. The current stock performance of Ulta Beauty shows a 52-week-high of $490.98 and a 52-week-low of $330.80. Moreover, at the end of the last trading period, the closing price was at $488.94.

According to Morgan Stanley, the prior rating for Baxter International Inc BAX was changed from Overweight to Equal-Weight. In the third quarter, Baxter Intl showed an EPS of $0.82, compared to $1.02 from the year-ago quarter. The current stock performance of Baxter Intl shows a 52-week-high of $89.70 and a 52-week-low of $49.00. Moreover, at the end of the last trading period, the closing price was at $52.57.

Morgan Stanley downgraded the previous rating for Doximity Inc DOCS from Equal-Weight to Underweight. For the second quarter, Doximity had an EPS of $0.17, compared to year-ago quarter EPS of $0.19. The stock has a 52-week-high of $64.95 and a 52-week-low of $22.91. At the end of the last trading period, Doximity closed at $32.01.

According to Scotiabank, the prior rating for Confluent Inc CFLT was changed from Sector Outperform to Sector Perform. Confluent earned $0.13 in the third quarter, compared to $0.17 in the year-ago quarter. The stock has a 52-week-high of $81.11 and a 52-week-low of $16.48. At the end of the last trading period, Confluent closed at $17.93.

Barclays downgraded the previous rating for UWM Holdings Corp UWMC from Equal-Weight to Underweight. For the third quarter, UWM Hldgs had an EPS of $0.16, compared to year-ago quarter EPS of $0.16. The stock has a 52-week-high of $6.10 and a 52-week-low of $2.84. At the end of the last trading period, UWM Hldgs closed at $3.59.

According to Barclays, the prior rating for Synchrony Financial SYF was changed from Overweight to Equal-Weight. For the third quarter, Synchrony Finl had an EPS of $1.47, compared to year-ago quarter EPS of $2.00. At the moment, the stock has a 52-week-high of $50.20 and a 52-week-low of $27.21. Synchrony Finl closed at $31.98 at the end of the last trading period.

For Fate Therapeutics Inc FATE, Wedbush downgraded the previous rating of Outperform to Neutral. For the third quarter, Fate Therapeutics had an EPS of $0.86, compared to year-ago quarter EPS of $0.45. The current stock performance of Fate Therapeutics shows a 52-week-high of $56.64 and a 52-week-low of $9.56. Moreover, at the end of the last trading period, the closing price was at $11.00.

According to SVB Leerink, the prior rating for Graphite Bio Inc GRPH was changed from Outperform to Market Perform. For the third quarter, Graphite Bio had an EPS of $0.45, compared to year-ago quarter EPS of $0.28. At the moment, the stock has a 52-week-high of $12.98 and a 52-week-low of $2.07. Graphite Bio closed at $3.06 at the end of the last trading period.

According to Wells Fargo, the prior rating for Bloom Energy Corp BE was changed from Overweight to Equal-Weight. In the third quarter, Bloom Energy showed an EPS of $0.20, compared to $0.20 from the year-ago quarter. The current stock performance of Bloom Energy shows a 52-week-high of $31.47 and a 52-week-low of $11.47. Moreover, at the end of the last trading period, the closing price was at $19.16.

Wells Fargo downgraded the previous rating for The RealReal Inc REAL from Overweight to Equal-Weight. For the third quarter, The RealReal had an EPS of $0.38, compared to year-ago quarter EPS of $0.47. The stock has a 52-week-high of $12.58 and a 52-week-low of $1.04. At the end of the last trading period, The RealReal closed at $1.20.

Raymond James downgraded the previous rating for Envestnet Inc ENV from Strong Buy to Outperform. For the third quarter, Envestnet had an EPS of $0.45, compared to year-ago quarter EPS of $0.61. The current stock performance of Envestnet shows a 52-week-high of $84.58 and a 52-week-low of $41.72. Moreover, at the end of the last trading period, the closing price was at $62.66.

For Radian Group Inc RDN, Barclays downgraded the previous rating of Overweight to Equal-Weight. Radian Group earned $1.31 in the third quarter, compared to $0.67 in the year-ago quarter. The stock has a 52-week-high of $24.84 and a 52-week-low of $17.84. At the end of the last trading period, Radian Group closed at $18.93.

According to Wells Fargo, the prior rating for NovoCure Ltd NVCR was changed from Overweight to Equal-Weight. In the third quarter, NovoCure showed an EPS of $0.25, compared to $0.13 from the year-ago quarter. At the moment, the stock has a 52-week-high of $120.03 and a 52-week-low of $56.39. NovoCure closed at $118.81 at the end of the last trading period.

According to Barclays, the prior rating for PennyMac Financial Services Inc PFSI was changed from Overweight to Equal-Weight. For the third quarter, PennyMac Financial Servs had an EPS of $2.46, compared to year-ago quarter EPS of $3.80. At the moment, the stock has a 52-week-high of $70.44 and a 52-week-low of $38.53. PennyMac Financial Servs closed at $58.55 at the end of the last trading period.

Barclays downgraded the previous rating for Oportun Financial Corp OPRT from Overweight to Equal-Weight. In the third quarter, Oportun Financial showed an EPS of $0.25, compared to $0.78 from the year-ago quarter. At the moment, the stock has a 52-week-high of $21.39 and a 52-week-low of $4.03. Oportun Financial closed at $5.55 at the end of the last trading period.

Barclays downgraded the previous rating for OneMain Holdings Inc OMF from Overweight to Equal-Weight. In the third quarter, OneMain Holdings showed an EPS of $1.51, compared to $2.37 from the year-ago quarter. The stock has a 52-week-high of $55.50 and a 52-week-low of $28.77. At the end of the last trading period, OneMain Holdings closed at $34.42.

Barclays downgraded the previous rating for NMI Holdings Inc NMIH from Overweight to Equal-Weight. In the third quarter, NMI Holdings showed an EPS of $0.90, compared to $0.71 from the year-ago quarter. The current stock performance of NMI Holdings shows a 52-week-high of $27.25 and a 52-week-low of $15.33. Moreover, at the end of the last trading period, the closing price was at $20.80.

For MGIC Investment Corp MTG, Barclays downgraded the previous rating of Overweight to Equal-Weight. MGIC Investment earned $0.86 in the third quarter, compared to $0.46 in the year-ago quarter. The current stock performance of MGIC Investment shows a 52-week-high of $16.84 and a 52-week-low of $11.38. Moreover, at the end of the last trading period, the closing price was at $12.90.

Barclays downgraded the previous rating for Essent Group Ltd ESNT from Overweight to Equal-Weight. In the third quarter, Essent Gr showed an EPS of $1.66, compared to $1.84 from the year-ago quarter. The stock has a 52-week-high of $50.17 and a 52-week-low of $34.27. At the end of the last trading period, Essent Gr closed at $38.56.

According to Wells Fargo, the prior rating for Bath & Body Works Inc BBWI was changed from Overweight to Equal-Weight. In the third quarter, Bath & Body Works showed an EPS of $0.40, compared to $0.92 from the year-ago quarter. The current stock performance of Bath & Body Works shows a 52-week-high of $71.49 and a 52-week-low of $25.75. Moreover, at the end of the last trading period, the closing price was at $46.79.

According to Barclays, the prior rating for Discover Financial Services DFS was changed from Overweight to Equal-Weight. For the third quarter, Discover Financial had an EPS of $3.54, compared to year-ago quarter EPS of $3.54. At the moment, the stock has a 52-week-high of $130.81 and a 52-week-low of $87.64. Discover Financial closed at $99.55 at the end of the last trading period.

For VF Corp VFC, Wells Fargo downgraded the previous rating of Equal-Weight to Underweight. In the second quarter, VF showed an EPS of $0.73, compared to $1.11 from the year-ago quarter. The stock has a 52-week-high of $76.61 and a 52-week-low of $25.05. At the end of the last trading period, VF closed at $29.45.

For Lincoln National Corp LNC, JP Morgan downgraded the previous rating of Overweight to Neutral. For the third quarter, Lincoln National had an EPS of $1.39, compared to year-ago quarter EPS of $1.62. The stock has a 52-week-high of $76.40 and a 52-week-low of $28.61. At the end of the last trading period, Lincoln National closed at $31.16.

According to JP Morgan, the prior rating for Silvergate Capital Corp SI was changed from Overweight to Neutral. For the third quarter, Silvergate Capital had an EPS of $1.28, compared to year-ago quarter EPS of $0.88. The stock has a 52-week-high of $162.65 and a 52-week-low of $11.14. At the end of the last trading period, Silvergate Capital closed at $12.57.

According to Jefferies, the prior rating for Landos Biopharma Inc LABP was changed from Hold to Underperform. In the third quarter, Landos Biopharma showed an EPS of $0.20, compared to $0.32 from the year-ago quarter. The stock has a 52-week-high of $4.92 and a 52-week-low of $0.21. At the end of the last trading period, Landos Biopharma closed at $0.54.

Cowen & Co. downgraded the previous rating for Fate Therapeutics Inc FATE from Outperform to Market Perform. In the third quarter, Fate Therapeutics showed an EPS of $0.86, compared to $0.45 from the year-ago quarter. The stock has a 52-week-high of $56.64 and a 52-week-low of $9.56. At the end of the last trading period, Fate Therapeutics closed at $11.00.

For Constellation Brands Inc STZ, Cowen & Co. downgraded the previous rating of Outperform to Market Perform. In the third quarter, Constellation Brands showed an EPS of $2.83, compared to $3.12 from the year-ago quarter. At the moment, the stock has a 52-week-high of $261.52 and a 52-week-low of $207.59. Constellation Brands closed at $208.68 at the end of the last trading period.

According to Jefferies, the prior rating for Nuvation Bio Inc NUVB was changed from Buy to Hold. In the third quarter, Nuvation Bio showed an EPS of $0.12, compared to $0.11 from the year-ago quarter. The current stock performance of Nuvation Bio shows a 52-week-high of $8.05 and a 52-week-low of $1.59. Moreover, at the end of the last trading period, the closing price was at $2.03.

According to Raymond James, the prior rating for AnaptysBio Inc ANAB was changed from Outperform to Market Perform. For the third quarter, AnaptysBio had an EPS of $1.18, compared to year-ago quarter EPS of $0.24. The current stock performance of AnaptysBio shows a 52-week-high of $35.70 and a 52-week-low of $18.20. Moreover, at the end of the last trading period, the closing price was at $30.21.

Needham downgraded the previous rating for NuVasive Inc NUVA from Buy to Hold. For the third quarter, NuVasive had an EPS of $0.54, compared to year-ago quarter EPS of $0.32. At the moment, the stock has a 52-week-high of $60.47 and a 52-week-low of $35.17. NuVasive closed at $42.37 at the end of the last trading period.

For Truist Financial Corp TFC, Deutsche Bank downgraded the previous rating of Buy to Hold. In the third quarter, Truist Financial showed an EPS of $1.24, compared to $1.42 from the year-ago quarter. The current stock performance of Truist Financial shows a 52-week-high of $68.95 and a 52-week-low of $40.01. Moreover, at the end of the last trading period, the closing price was at $44.44.

For Bank of America Corp BAC, Deutsche Bank downgraded the previous rating of Buy to Hold. Bank of America earned $0.81 in the third quarter, compared to $0.85 in the year-ago quarter. At the moment, the stock has a 52-week-high of $50.11 and a 52-week-low of $29.31. Bank of America closed at $34.07 at the end of the last trading period.

For JPMorgan Chase & Co JPM, Deutsche Bank downgraded the previous rating of Buy to Hold. In the third quarter, JPMorgan Chase showed an EPS of $3.12, compared to $3.74 from the year-ago quarter. The current stock performance of JPMorgan Chase shows a 52-week-high of $169.81 and a 52-week-low of $101.28. Moreover, at the end of the last trading period, the closing price was at $135.35.

Baird downgraded the previous rating for Triumph Group Inc TGI from Outperform to Neutral. For the second quarter, Triumph Group had an EPS of $0.07, compared to year-ago quarter EPS of $0.10. At the moment, the stock has a 52-week-high of $27.85 and a 52-week-low of $7.84. Triumph Group closed at $10.32 at the end of the last trading period.

For Nevro Corp NVRO, Piper Sandler downgraded the previous rating of Neutral to Underweight. For the third quarter, Nevro had an EPS of $0.59, compared to year-ago quarter EPS of $0.87. The stock has a 52-week-high of $93.69 and a 52-week-low of $34.70. At the end of the last trading period, Nevro closed at $40.00.

According to BMO Capital, the prior rating for Graphite Bio Inc GRPH was changed from Outperform to Market Perform. For the third quarter, Graphite Bio had an EPS of $0.45, compared to year-ago quarter EPS of $0.28. The stock has a 52-week-high of $12.98 and a 52-week-low of $2.07. At the end of the last trading period, Graphite Bio closed at $3.06.

For Fate Therapeutics Inc FATE, Piper Sandler downgraded the previous rating of Overweight to Neutral. Fate Therapeutics earned $0.86 in the third quarter, compared to $0.45 in the year-ago quarter. At the moment, the stock has a 52-week-high of $56.64 and a 52-week-low of $9.56. Fate Therapeutics closed at $11.00 at the end of the last trading period.

For Fate Therapeutics Inc FATE, BMO Capital downgraded the previous rating of Outperform to Market Perform. In the third quarter, Fate Therapeutics showed an EPS of $0.86, compared to $0.45 from the year-ago quarter. The stock has a 52-week-high of $56.64 and a 52-week-low of $9.56. At the end of the last trading period, Fate Therapeutics closed at $11.00.

For Fate Therapeutics Inc FATE, Truist Securities downgraded the previous rating of Buy to Hold. Fate Therapeutics earned $0.86 in the third quarter, compared to $0.45 in the year-ago quarter. The stock has a 52-week-high of $56.64 and a 52-week-low of $9.56. At the end of the last trading period, Fate Therapeutics closed at $11.00.

According to Baird, the prior rating for Getty Realty Corp GTY was changed from Outperform to Neutral. In the third quarter, Getty Realty showed an EPS of $0.54, compared to $0.50 from the year-ago quarter. The stock has a 52-week-high of $35.77 and a 52-week-low of $24.66. At the end of the last trading period, Getty Realty closed at $34.43.

For Kite Realty Group Trust KRG, Baird downgraded the previous rating of Outperform to Neutral. For the third quarter, Kite Realty Gr Trust had an EPS of $0.48, compared to year-ago quarter EPS of $0.33. The current stock performance of Kite Realty Gr Trust shows a 52-week-high of $23.35 and a 52-week-low of $16.42. Moreover, at the end of the last trading period, the closing price was at $21.02.

See all analyst ratings downgrades.

Initiations

Dawson James initiated coverage on Zomedica Corp ZOM with a Buy rating. The price target for Zomedica is set to $6.00. For the third quarter, Zomedica had an EPS of $0.01, compared to year-ago quarter EPS of $0.01. The current stock performance of Zomedica shows a 52-week-high of $0.50 and a 52-week-low of $0.15. Moreover, at the end of the last trading period, the closing price was at $0.19.

Credit Suisse initiated coverage on NewAmsterdam Pharma Co NV NAMS with an Outperform rating. The price target for NewAmsterdam Pharma is set to $21.00. The stock has a 52-week-high of $32.88 and a 52-week-low of $7.52. At the end of the last trading period, NewAmsterdam Pharma closed at $11.93.

Morgan Stanley initiated coverage on Desktop Metal Inc DM with a Equal-Weight rating. The price target for Desktop Metal is set to $1.75. In the third quarter, Desktop Metal showed an EPS of $0.10, compared to $0.10 from the year-ago quarter. The current stock performance of Desktop Metal shows a 52-week-high of $5.28 and a 52-week-low of $1.13. Moreover, at the end of the last trading period, the closing price was at $1.39.

With a Equal-Weight rating, Morgan Stanley initiated coverage on Otis Worldwide Corp OTIS. The price target seems to have been set at $84.00 for Otis Worldwide. For the third quarter, Otis Worldwide had an EPS of $0.80, compared to year-ago quarter EPS of $0.77. At the moment, the stock has a 52-week-high of $87.68 and a 52-week-low of $62.49. Otis Worldwide closed at $80.13 at the end of the last trading period.

Barclays initiated coverage on Ziff Davis Inc ZD with a Equal-Weight rating. The price target for Ziff Davis is set to $88.00. For the third quarter, Ziff Davis had an EPS of $1.58, compared to year-ago quarter EPS of $2.34. The current stock performance of Ziff Davis shows a 52-week-high of $112.93 and a 52-week-low of $66.85. Moreover, at the end of the last trading period, the closing price was at $79.22.

Exane BNP Paribas initiated coverage on Equifax Inc EFX with an Underperform rating. The price target for Equifax is set to $150.00. In the third quarter, Equifax showed an EPS of $1.73, compared to $1.85 from the year-ago quarter. The stock has a 52-week-high of $288.98 and a 52-week-low of $145.98. At the end of the last trading period, Equifax closed at $198.10.

Exane BNP Paribas initiated coverage on TransUnion TRU with a Neutral rating. The price target for TransUnion is set to $64.50. TransUnion earned $0.93 in the third quarter, compared to $1.01 in the year-ago quarter. The current stock performance of TransUnion shows a 52-week-high of $118.49 and a 52-week-low of $50.32. Moreover, at the end of the last trading period, the closing price was at $59.33.

With a Buy rating, B of A Securities initiated coverage on Boot Barn Holdings Inc BOOT. The price target seems to have been set at $85.00 for Boot Barn Holdings. Boot Barn Holdings earned $1.06 in the second quarter, compared to $1.22 in the year-ago quarter. The current stock performance of Boot Barn Holdings shows a 52-week-high of $126.60 and a 52-week-low of $50.20. Moreover, at the end of the last trading period, the closing price was at $63.00.

B of A Securities initiated coverage on Celsius Holdings Inc CELH with a Neutral rating. The price target for Celsius Holdings is set to $104.00. In the third quarter, Celsius Holdings showed an EPS of $0.67, compared to $0.03 from the year-ago quarter. The current stock performance of Celsius Holdings shows a 52-week-high of $122.24 and a 52-week-low of $38.31. Moreover, at the end of the last trading period, the closing price was at $101.23.

With an Overweight rating, Cantor Fitzgerald initiated coverage on Silver Spike Investment Corp SSIC. The price target seems to have been set at $15.30 for Silver Spike Investment.

With a Buy rating, Citigroup initiated coverage on Waste Management Inc WM. The price target seems to have been set at $183.00 for Waste Management. For the third quarter, Waste Management had an EPS of $1.56, compared to year-ago quarter EPS of $1.26. The current stock performance of Waste Management shows a 52-week-high of $175.98 and a 52-week-low of $138.58. Moreover, at the end of the last trading period, the closing price was at $153.88.

Wells Fargo initiated coverage on Snowflake Inc SNOW with an Overweight rating. The price target for Snowflake is set to $170.00. For the third quarter, Snowflake had an EPS of $0.11, compared to year-ago quarter EPS of $0.04. The stock has a 52-week-high of $329.49 and a 52-week-low of $110.27. At the end of the last trading period, Snowflake closed at $121.56.

See all analyst ratings initiations.